What is Macula Risk® PGx?
"Earlier detection, earlier treatment, better visual outcomes"
Macula Risk® PGx is a combined prognostic and pharmacogenetic DNA test for patients who have a diagnosis of early or intermediate Age-Related Macular Degeneration (AMD).
The sample is a simple cheek swab ordered by your doctor to determine:
- Patient's risk of progressing to advanced AMD within 2, 5 and 10 years using an analysis of specific AMD risk genes, clinical AMD status and significant non-genetic risk factors (age, smoking history and body mass index, or BMI).
- The appropriate eye vitamin therapy for maximum vision preservation based on the patient’s specific genetic profile.
Discuss with your doctor whether the Macula Risk PGx test is right for you.